Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Cash: 2020-2025

Historic Change in Cash for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $2.2 million.

  • iSpecimen's Change in Cash rose 649.33% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 206.31%. This contributed to the annual value of -$465,258 for FY2024, which is 96.41% up from last year.
  • Per iSpecimen's latest filing, its Change in Cash stood at $2.2 million for Q3 2025, which was up 1,232.16% from -$193,788 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Change in Cash registered a high of $17.9 million during Q4 2021, and its lowest value of -$11.5 million during Q1 2023.
  • In the last 3 years, iSpecimen's Change in Cash had a median value of -$253,775 in 2024 and averaged -$1.1 million.
  • Over the last 5 years, iSpecimen's Change in Cash had its largest YoY gain of 6,967.86% in 2021, and its largest YoY loss of 888.48% in 2021.
  • iSpecimen's Change in Cash (Quarterly) stood at $17.9 million in 2021, then plummeted by 129.80% to -$5.3 million in 2022, then soared by 92.94% to -$377,902 in 2023, then surged by 133.49% to $126,554 in 2024, then surged by 649.33% to $2.2 million in 2025.
  • Its Change in Cash stands at $2.2 million for Q3 2025, versus -$193,788 for Q2 2025 and -$1.1 million for Q1 2025.